Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Merck
Mallinckrodt
Chubb
Fish and Richardson
Daiichi Sankyo
McKinsey
Teva

Generated: May 20, 2018

DrugPatentWatch Database Preview

CAPECITABINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Capecitabine, and what generic alternatives are available?

Capecitabine is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms, Eugia Pharma, Mylan Pharms Inc, Shilpa Medicare Ltd, Teva Pharms Usa, and West-ward Pharms Int. and is included in eight NDAs.

The generic ingredient in CAPECITABINE is capecitabine. There are twenty-eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the capecitabine profile page.
Drug patent expirations by year for CAPECITABINE
Pharmacology for CAPECITABINE
Medical Subject Heading (MeSH) Categories for CAPECITABINE

US Patents and Regulatory Information for CAPECITABINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CAPECITABINE capecitabine TABLET;ORAL 202593-001 Apr 23, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eugia Pharma CAPECITABINE capecitabine TABLET;ORAL 210604-001 Apr 17, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd CAPECITABINE capecitabine TABLET;ORAL 207652-002 Nov 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shilpa Medicare Ltd CAPECITABINE capecitabine TABLET;ORAL 207456-002 Dec 12, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Merck
Argus Health
Cipla
Teva
Harvard Business School
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.